As lobular inflammation and ballooning are the main factors promoting the development of liver fibrosis in NAFLD people, DNA methylation of Smpd3 in the current study will be significant in risk stratification as a novel potential biomarker. This evidence concerns the gene SMPD3 and metabolic dysfunction-associated steatotic liver disease.